Olema Pharmaceuticals, Inc. (OLMA) Earnings
|
Expand Research on OLMA
| Next EPS Date | 11/10/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/10/26  |
Q326 | N/A | -$0.63 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$0.61 | -$0.55 | -$0.06 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 | Q126 | -$0.52 | -$0.53 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 3/16/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/10/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/9/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/6/26 |
Q425 | N/A | -$0.52 | N/A | N/A | N/A | N/A | N/A | N/A |
